A pharmacoeconomic evaluation of major depressive disorder.
Casciano
Roman
R
Analytica Group, Ltd., New York City, USA.
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D019091:Critical Pathways; D003511:Cyclohexanols / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D003663:Decision Trees; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000191:economics*; D017850:Economics, Pharmaceutical; D006801:Humans; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride